Fingerprinting Your LNP Drug Product Quality, Safety, Efficacy & Regulatory Compliance

With the recent breakthroughs from Verve Therapeutics, Vertex-Arbor Bio, and Mana.bio propelling the field of LNP technology forward at lightning speed beyond mRNA vaccines, the LNP Characterization & Analytical Development Summit is your must-attend meeting to deep dive into the latest technologies and approaches throughout product lifecycle and strengthen your lipid nanoparticle characterization, bioanalytical and assay development competencies.

With unmissable case studies from the likes of Pfizer, Moderna, AstraZeneca, Ultranegyx, Merck and SINTEF, this is the definitive forum to benchmark and learn with the LNP community who unite for the first time.

These industry titans have collaborated to form a comprehensive, 3-day program covering key topics including:

• Analyze LNP structure and morphology to relay into functional data and analytical practices with Ultragenyx and Pfizer
• Optimize the characterization of payloads to foresee the outcome of the LNP complex with Hopewell Therapeutics, Beam Therapeutics and Moderna
• Develop assays which align with mechanisms of action and portray total functionality of the LNP with NIST, Editas Medicine and AstraZeneca

Don’t miss this opportunity to supercharge your analytics, and together with 60+ characterization and analytical scientists, get inspiration to derive best practice, and support next generation of therapeutics to patients with safety and efficacy.

To know more visit: https://ter.li/z7dmih